16:08 EDT Stoke Therapeutics (STOK) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STOK:
- Stoke Therapeutics price target raised to $38 from $36 at Wedbush
- STOK Earnings this Week: How Will it Perform?
- Stoke Therapeutics, Biogen publish data from zorevunersen studies in NEJM
- Nanogen appoints Ruff as Chief Regulatory Affairs Officer, McSherry as SVP
- Stoke Therapeutics Awards Discretionary Bonus to CEO Smith